Pictet Asset Management (Switzerland)’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-586,303
Closed -$4.53M 1678
2022
Q1
$4.53M Sell
586,303
-21,978
-4% -$247K 0.01% 829
2021
Q4
$8.58M Sell
608,281
-10,349
-2% -$153K 0.01% 711
2021
Q3
$10.8M Buy
+618,630
New +$10.9M 0.01% 652

Other funds holding SOPH

Pictet Asset Management (Switzerland)'s SOPH Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of SOPHiA GENETICS (SOPH) in Q2 2022, closing a stake of 586,303 shares — an estimated $4.53M sold.

Pictet Asset Management (Switzerland) first reported a position in SOPH in Q3 2021 and held it in 3 quarters. The position peaked at $10.8M in Q3 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2022.

  • Pictet Asset Management (Switzerland) reported no remaining SOPHiA GENETICS position as of Q2 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 586,303 SOPHiA GENETICS shares in Q2 2022, an estimated $4.53M.
  • Pictet Asset Management (Switzerland) first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 3 quarters.
  • Pictet Asset Management (Switzerland)'s SOPHiA GENETICS position peaked at $10.8M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.